Novel Lipid-Lowering Therapies: From Prominent to Horizon

In this online course, Michael J. Blaha, M.D., MPH discusses the current guidelines for lipid-lowering therapy, introduces new concepts using existing therapies and reviews the latest data on non-statin lipid-lowering therapies. 

Commercial Supporter

Baptist Health gratefully acknowledges the educational grants provided by Novartis Pharmaceuticals Corporation.

Target Audience

Internal Medicine Physicians, Family Medicine Physicians, Obstetricians, Hospitalists, Fellows, Physician Assistants/Physician Associates, Residents, Advanced Practice Registered Nurses, Nurses, Pharmacists, Pharmacy Technicians and all other interested healthcare providers.

Learning Objectives

  • Review existing lipid-lowering guidelines.
  • Discuss emerging concepts in lipid management by analyzing the efficacy and application of existing therapies.
  • Assess the latest data on non-statin lipid lowering therapies, evaluating their role in comprehensive lipid management plans.
Additional information
Bibliography: 
  • Nurmohamed, N. S., Navar, A. M., & Kastelein, J. J. (2021). New and emerging therapies for reduction of LDL-cholesterol and apolipoprotein B: JACC focus seminar 1/4. Journal of the American College of Cardiology, 77(12), 1564-1575.
  • Writing Committee, Lloyd-Jones, D. M., Morris, P. B., Ballantyne, C. M., Birtcher, K. K., Covington, A. M., ... & Wilkins, J. T. (2022). 2022 ACC expert consensus decision pathway on the role of nonstatin therapies for LDL-cholesterol lowering in the management of atherosclerotic cardiovascular disease risk: a report of the American College of Cardiology Solution Set Oversight Committee. Journal of the American College of Cardiology, 80(14), 1366-1418.
  • Wright, R. S., Ray, K. K., Raal, F. J., Kallend, D. G., Jaros, M., Koenig, W., ... & ORION Phase III Investigators. (2021). Pooled patient-level analysis of inclisiran trials in patients with familial hypercholesterolemia or atherosclerosis. Journal of the American College of Cardiology, 77(9), 1182-1193.
Course Summary
Available credit: 
  • 1.00 ABIM MOC II
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 General certificate of attendance
  • 1.00 Nurse Practitioners
  • 1.00 Florida Board of Nursing
  • 1.00 Florida Board of Pharmacy
Course opens: 
10/01/2024
Course expires: 
09/30/2027

Michael J. Blaha, M.D., MPH
Director of Clinical Research
Ciccarone Center for the Prevention of Cardiovascular Disease
Professor of Medicine
Johns Hopkins Medicine
Baltimore, Maryland

Michael Blaha, M.D., faculty for this educational activity, is a consultant for Scene Health and Kowa; an adviser for Novartis, Novo Nordisk, Bayer, Eli Lilly, Merck, Amgen, Roche, AstraZeneca, Boehringer Ingelheim, Vectura and Agepha; and a speaker for Novo Nordisk. He receives grant and research support from Bayer, Amgen and Novo Nordisk.  He has indicated that the presentation or discussion will not include off-label or unapproved product usage.

John Rubin, M.D., conference director for this educational activity, indicated that he is a shareholder in AstraZeneca and Bristol Myers Squibb. 

All the relevant financial relationships listed for these individuals have been mitigated.

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose with ineligible companies.*

*Ineligible companies - Companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
              
Baptist Health South Florida designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Internal Medicine Maintenance of Certification

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1 Medical Knowledge MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Your participation information will be shared with specialty boards through the ACCME's PARS reporting system. Successful completion of a course examination is required. Submissions are recorded in approximately 48 hours. You will receive an email when your credits have been processed.

Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

Available Credit

  • 1.00 ABIM MOC II
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 General certificate of attendance
  • 1.00 Nurse Practitioners
  • 1.00 Florida Board of Nursing
  • 1.00 Florida Board of Pharmacy
Please login or register for a Baptist Health CME account to take this course.

Your participation information will be shared with specialty boards through the ACCME's PARS reporting system. Successful completion of a course examination is required. Submissions are recorded in approximately 48 hours. You will receive an email when your credits have been processed.

Required Hardware/Software

PC/Mac Users
PC/Mac Users

This site is supported on the most recent stable releases of the following browsers:

Click Here to Download Google Chrome
Google Chrome
Microsoft Edge
Microsoft Edge
Safari
Safari
Moxilla Firefox
Mozilla Firefox
Mobile Users
Mobile Users

This site is supported on the following mobile devices:

  • Apple iOS mobile devices running iOS 10 or later
  • Android mobile devices running Android 4.4 or later, with the latest release of Google Chrome or Mozilla Firefox
Technical Support
Technical Support

If you are experiencing technical difficulties or have received an error message, please send an email to CME@baptisthealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.